BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36094328)

  • 1. The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes.
    Welter N; Brzezinski J; Treece A; Chintagumpala M; Young MD; Perotti D; Kieran K; Jongmans MCJ; Murphy AJ
    Pediatr Blood Cancer; 2023 May; 70 Suppl 2():e29984. PubMed ID: 36094328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study.
    Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski C; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
    Res Sq; 2023 Mar; ():. PubMed ID: 36993649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
    Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
    Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
    Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
    Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratification of Wilms tumor by genetic and epigenetic analysis.
    Scott RH; Murray A; Baskcomb L; Turnbull C; Loveday C; Al-Saadi R; Williams R; Breatnach F; Gerrard M; Hale J; Kohler J; Lapunzina P; Levitt GA; Picton S; Pizer B; Ronghe MD; Traunecker H; Williams D; Kelsey A; Vujanic GM; Sebire NJ; Grundy P; Stiller CA; Pritchard-Jones K; Douglas J; Rahman N
    Oncotarget; 2012 Mar; 3(3):327-35. PubMed ID: 22470196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan.
    Lu MY; Wang WC; Hou TC; Kuo CY; Lai YC
    Pathol Oncol Res; 2020 Oct; 26(4):2153-2159. PubMed ID: 32157637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
    Fiala EM; Ortiz MV; Kennedy JA; Glodzik D; Fleischut MH; Duffy KA; Hathaway ER; Heaton T; Gerstle JT; Steinherz P; Shukla N; McNeer N; Tkachuk K; Bouvier N; Cadoo K; Carlo MI; Latham A; Dubard Gault M; Joseph V; Kemel Y; Kentsis A; Stadler Z; La Quaglia M; Papaemmanuil E; Friedman D; Ganguly A; Kung A; Offit K; Kalish JM; Walsh MF
    Cancer; 2020 Jul; 126(13):3114-3121. PubMed ID: 32320050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumor genes.
    Huff V; Saunders GF
    Biochim Biophys Acta; 1993 Dec; 1155(3):295-306. PubMed ID: 8268188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
    J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in Wilms' tumor predisposition.
    Maciaszek JL; Oak N; Nichols KE
    Hum Mol Genet; 2020 Oct; 29(R2):R138-R149. PubMed ID: 32412586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
    Stoltze UK; Hildonen M; Hansen TVO; Foss-Skiftesvik J; Byrjalsen A; Lundsgaard M; Pignata L; Grønskov K; Tumer Z; Schmiegelow K; Brok JS; Wadt KAW
    J Med Genet; 2023 Sep; 60(9):842-849. PubMed ID: 37019617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group.
    Hamilton TE; Ritchey ML; Haase GM; Argani P; Peterson SM; Anderson JR; Green DM; Shamberger RC
    Ann Surg; 2011 May; 253(5):1004-10. PubMed ID: 21394016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM28 haploinsufficiency predisposes to Wilms tumor.
    Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
    Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Moore C; Monforte H; Teer JK; Zhang Y; Yoder S; Brohl AS; Reed DR
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32699065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of Xp22.11 Duplication as a Germline Susceptibility Alteration in a Wilms Tumor Arising in Horseshoe Kidney.
    Zhou HF; Amarillo IE; Snyder S; Granadillo JL; O'Conor CJ; Dillon P; Wilson D; Huang FS; Dehner LP; He M
    Fetal Pediatr Pathol; 2022 Aug; 41(4):682-688. PubMed ID: 33960268
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral Wilms tumors treated according to the Japan Wilms Tumor Study Group protocol.
    Oue T; Koshinaga T; Okita H; Kaneko Y; Hinotsu S; Fukuzawa M
    Pediatr Blood Cancer; 2014 Jul; 61(7):1184-9. PubMed ID: 24623612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral Wilms' tumor: long-term survival and some epidemiological features.
    Coppes MJ; de Kraker J; van Dijken PJ; Perry HJ; Delemarre JF; Tournade MF; Lemerle J; Voûte PA
    J Clin Oncol; 1989 Mar; 7(3):310-5. PubMed ID: 2537383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.
    Perlman EJ; Grundy PE; Anderson JR; Jennings LJ; Green DM; Dome JS; Shamberger RC; Ruteshouser EC; Huff V
    J Clin Oncol; 2011 Feb; 29(6):698-703. PubMed ID: 21189373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.